Lacombe Guillaume, St-Onge Maude
Université Laval, Québec, Canada.
Quebec Poison Centre.
Emerg Med J. 2016 Jan;33(1):76-7. doi: 10.1136/emermed-2015-205558.1.
A shortcut review was carried out to establish whether silibinin is better than conservative management at reducing liver transplantation and death after poisoning with amatoxin-containing mushrooms. Thirty-eight papers were found in Medline and 86 in EMBASE using the reported searches. Of these, five presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these best papers are tabulated. It is concluded that the evidence is limited, but given the lack of alternative treatments in patients with suspected amatoxin-containing mushroom poisoning and the relatively few adverse effects, silibinin should be considered in some patients.
进行了一项简短综述,以确定水飞蓟宾在降低含鹅膏毒素蘑菇中毒后的肝移植率和死亡率方面是否优于保守治疗。通过报告的检索策略,在Medline数据库中找到38篇论文,在EMBASE数据库中找到86篇论文。其中,五篇提供了回答该临床问题的最佳证据。将这些最佳论文的作者、发表日期和国家、研究的患者群体、研究类型、相关结局、结果及研究不足制成表格。结论是证据有限,但鉴于疑似含鹅膏毒素蘑菇中毒患者缺乏替代治疗方法且不良反应相对较少,在某些患者中应考虑使用水飞蓟宾。